Omega Healthcare Investors Inc (OHI) Stock Analysis and Metrics

Omega Healthcare Investors

NYSE: OHI

$51.74 ▲ +0.76 (+1.50%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap15.14 Bn

P/E23.22

P/S12.25

Div. Yield0.05

Total Debt (Qtr)425.00 Mn

Add ratio to table…

About

Omega Healthcare Investors, Inc. is a Maryland corporation that invests in healthcare related real estate properties in the United States the United Kingdom and Canada and has elected to be taxed as a REIT. The company owns and operates a diversified portfolio of skilled nursing facilities assisted living facilities independent living facilities specialty facilities and continuing care retirement communities. It also provides real estate loans and uses RIDEA structures to generate income from property operations.

Omega Healthcare Investors, Inc. generates revenue primarily from triple net lease agreements where tenants pay rent and all operating expenses. It earns interest income from mortgage loans and other real estate loans secured by healthcare properties. The company receives management fees from RIDEA arrangements in which it contracts third party property managers to operate facilities. Additionally it records equity earnings from investments in unconsolidated entities and interest income from non real estate loans to operators.

The company operates through the following segments.

• Healthcare Real Estate Investments – This segment includes the acquisition and ownership of skilled nursing facilities assisted living facilities independent living facilities specialty facilities and continuing care retirement communities. It also encompasses real estate loans RIDEA structures and investments in unconsolidated entities that support the long term healthcare industry.

Omega Healthcare Investors, Inc. competes with other public and private REITs investment companies private equity hedge fund investors healthcare operators lenders developers and institutional investors for acquisitions of healthcare real estate. Its competitive advantages stem from a long term triple net lease structure that shifts operating costs to tenants a geographically diverse portfolio across multiple property types and a focus on partnering with creditworthy operators. The company’s scale and REIT status provide access to capital and tax efficiency while its use of RIDEA structures offers flexibility to participate in facility operations.

The company serves third party healthcare operating companies that lease its properties and third party property managers that manage facilities under RIDEA agreements. It also works with joint venture partners in unconsolidated entities that own or finance healthcare real estate.

Investment Thesis

▲ Bull case

Omega Healthcare Investors is positioned to capture sustained FAD per share growth through disciplined capital allocation into high-yielding RIDEA structures, particularly in the UK and U.S. senior housing, where management is actively pursuing mid-teens IRR opportunities. The company’s $326 million in year-to-date investments, including a $10 million Alabama senior housing RIDEA deal and a $7 million UK care home acquisition, reflect a strategic shift toward value-add platforms that allow participation in operating upside beyond triple-net leases. With a weighted average yield of 10.9% on new leases and loans year to date, OHI is deploying capital at spreads significantly above its cost of debt, enhancing accretive potential. Management’s emphasis on RIDEA in the UK, as noted by Vikas Gupta stating they are “looking at a few opportunities right now” and will make it “part of our strategy in the UK going forward,” signals an underappreciated geographic diversification catalyst. This expansion into the UK RIDEA market, combined with existing U.S. senior housing pipeline, provides a runway for mid-teens IRR execution that is not yet fully priced into the stock, especially as competitors remain focused on stabilized, lower-yielding assets. The Sabra operating company equity investment, which returned above expectations, further validates OHI’s ability to identify and benefit from operating company growth in adjacent healthcare services.
The strategic sale of 18 CommuniCare assets for $480 million at a 7.7% blended rent discount rate is not merely a divestiture but a capital recycling opportunity that management expects to generate $0.03 per share in annual AFFO and FAD accretion through redeployment into higher-yielding investments. Despite the seemingly modest cap rate, Matthew Gourmand indicated the company is targeting reinvestment yields in the “low 9%s” with expectations to deploy capital at 10% or higher, implying the accretion estimate is conservative. The sale also enhanced credit with CommuniCare, reducing tenant concentration risk and improving lease security in a core market. With $1.5 billion of available capacity on its $2 billion revolver and no major debt maturity until April 2027, OHI has exceptional financial flexibility to execute this redeployment without constraint. The trailing twelve-month EBITDAR coverage for its triple-net and mortgage core portfolio at 1.58x—the highest in over a decade—demonstrates improving tenant credit quality, which supports rent sustainability and reduces downside risk to cash flow. This strengthening fundamentals backdrop, combined with active portfolio management, creates a foundation for consistent FAD growth that the market may be underestimating given the company’s focus on sustainable, per-share expansion rather than aggressive multiple expansion.
Favorable industry tailwinds, particularly the limited new supply of skilled nursing facilities due to state-level restrictions, are creating a long-term secular tailwind that benefits OHI’s incumbent operators and supports rent growth potential. As Matthew Gourmand noted, the lack of net new supply for over a decade means that even operators entering at mid-6s yields can benefit from operating leverage as occupancy improves and facilities stabilize, eventually enabling refinancing to low-cost HUD debt. This dynamic enhances the value of OHI’s existing portfolio and supports gradual rent escalators and occupancy improvements tied to aging U.S. demographics. Megan Krull’s commentary that “the demographics are here and coming, and ultimately you will see that needle move” reflects confidence in a gradual but durable occupancy recovery, which, combined with annual rent escalators, provides a predictable tailwind to NOI growth. The company’s focus on partnering with sophisticated operators who can navigate value-based care and Medicare Advantage pressures—despite its low penetration in their business—further reduces operational risk. These structural advantages, not temporary cyclical factors, position OHI to benefit from a multi-decade demographic wave that is underappreciated in current valuations focused on near-term headwinds.

Omega Healthcare Investors is positioned to capture sustained FAD per share growth through disciplined capital allocation into high-yielding RIDEA structures, particularly in the UK and U.S. senior housing, where management is actively pursuing mid-teens IRR opportunities. The company’s $326 million in year-to-date investments, including a $10 million Alabama senior housing RIDEA deal and a $7 million UK care home acquisition, reflect a strategic shift toward value-add platforms that allow participation in operating upside beyond triple-net leases. With a weighted average yield of 10.9% on new leases and loans year to date, OHI is deploying capital at spreads significantly above its cost of debt, enhancing accretive potential. Management’s emphasis on RIDEA in the UK, as noted by Vikas Gupta stating they are “looking at a few opportunities right now” and will make it “part of our strategy in the UK going forward,” signals an underappreciated geographic diversification catalyst. This expansion into the UK RIDEA market, combined with existing U.S. senior housing pipeline, provides a runway for mid-teens IRR execution that is not yet fully priced into the stock, especially as competitors remain focused on stabilized, lower-yielding assets. The Sabra operating company equity investment, which returned above expectations, further validates OHI’s ability to identify and benefit from operating company growth in adjacent healthcare services.
The strategic sale of 18 CommuniCare assets for $480 million at a 7.7% blended rent discount rate is not merely a divestiture but a capital recycling opportunity that management expects to generate $0.03 per share in annual AFFO and FAD accretion through redeployment into higher-yielding investments. Despite the seemingly modest cap rate, Matthew Gourmand indicated the company is targeting reinvestment yields in the “low 9%s” with expectations to deploy capital at 10% or higher, implying the accretion estimate is conservative. The sale also enhanced credit with CommuniCare, reducing tenant concentration risk and improving lease security in a core market. With $1.5 billion of available capacity on its $2 billion revolver and no major debt maturity until April 2027, OHI has exceptional financial flexibility to execute this redeployment without constraint. The trailing twelve-month EBITDAR coverage for its triple-net and mortgage core portfolio at 1.58x—the highest in over a decade—demonstrates improving tenant credit quality, which supports rent sustainability and reduces downside risk to cash flow. This strengthening fundamentals backdrop, combined with active portfolio management, creates a foundation for consistent FAD growth that the market may be underestimating given the company’s focus on sustainable, per-share expansion rather than aggressive multiple expansion.
Favorable industry tailwinds, particularly the limited new supply of skilled nursing facilities due to state-level restrictions, are creating a long-term secular tailwind that benefits OHI’s incumbent operators and supports rent growth potential. As Matthew Gourmand noted, the lack of net new supply for over a decade means that even operators entering at mid-6s yields can benefit from operating leverage as occupancy improves and facilities stabilize, eventually enabling refinancing to low-cost HUD debt. This dynamic enhances the value of OHI’s existing portfolio and supports gradual rent escalators and occupancy improvements tied to aging U.S. demographics. Megan Krull’s commentary that “the demographics are here and coming, and ultimately you will see that needle move” reflects confidence in a gradual but durable occupancy recovery, which, combined with annual rent escalators, provides a predictable tailwind to NOI growth. The company’s focus on partnering with sophisticated operators who can navigate value-based care and Medicare Advantage pressures—despite its low penetration in their business—further reduces operational risk. These structural advantages, not temporary cyclical factors, position OHI to benefit from a multi-decade demographic wave that is underappreciated in current valuations focused on near-term headwinds.

▼ Bear case

Omega Healthcare Investors faces mounting competitive pressures in its core skilled nursing and senior housing investment markets, which may constrain its ability to deploy capital at accretive yields despite a robust pipeline. Vikas Gupta acknowledged that the transaction market for U.S. senior housing and RIDEA structures is seeing “a lot of capital flowing into this space,” making it increasingly difficult to achieve the mid-teens IRRs the company targets. Similarly, in the SNF space, William John Kilichowski of Wells Fargo noted the market remains “heavily competitive,” with limited trading that fits OHI’s investment criteria, and Vikas Gupta confirmed they are “just not seeing a lot of trading at this time that we like and that fits our investment criteria.” This heightened competition risks forcing OHI to either lower its underwriting standards or sit on sidelines, potentially undermining its FAD per share growth trajectory. The company’s reliance on off-market deals and relationship-based sourcing, while a strength, may not be scalable enough to offset broad-based capital inflows that are compressing cap rates and reducing available spread. If OHI cannot consistently find value-add opportunities at its hurdle rates, its growth projections—particularly the mid-teens IRR RIDEA pipeline—could prove overly optimistic, leading to lower-than-expected reinvestment yields from asset sales like the CommuniCare disposition.
The Genesis bankruptcy exposure, while currently managed through a $25 million DIP loan funding, presents an unquantified risk that could materialize if the asset transfer to 101 West State Street fails or is delayed, potentially leaving OHI with impaired collateral and reduced recovery prospects. Although management expressed confidence that the term loan is “fully collateralized” and expects full payoff upon asset transfer, Vikas Gupta explicitly noted that “these assumptions, along with all elements of the bankruptcy process, are subject to further developments and events in the bankruptcy proceeding.” The closing date for the asset purchase agreement can be contractually extended to the end of Q3, and success is conditioned on regulatory change-of-ownership approval—an external factor outside OHI’s control. Any adverse development in the Genesis case, such as a rejection of lease obligations or a decline in the ascribed value of the estate, could result in a partial or total loss on the DIP and term loan exposure. While OHI frames this as a contained event, the lack of discussion around downside scenarios or stress testing suggests the market may be underestimating the binary nature of this risk, which could impact earnings and confidence if not resolved as anticipated.
Despite strong portfolio coverage metrics, Omega Healthcare Investors’ occupancy trends remain stagnant, calling into question the timing and durability of the expected recovery tied to demographic trends. Megan Krull acknowledged that “the past few quarters have kind of stagnated” and admitted there is “no read-through over a few quarters as to what occupancy is doing,” while expressing confidence that improvement will come “in the next year or two.” This vague outlook contrasts with the company’s reliance on gradual occupancy improvement as a driver of NOI growth and rent escalators, particularly in its triple-net portfolio. If occupancy fails to rebound as expected—due to persistent staffing shortages, shifting patient acuity, or slower-than-anticipated demographic demand—EBITDAR coverage could deteriorate, threatening the 1.58x ratio and increasing rent default risk. Furthermore, the company’s heavy reliance on annual rent escalators (which contributed $2 million to Q1 revenue growth) may mask underlying weakness in fundamental operating performance. The market may be ignoring the risk that OHI’s cash flow stability is more dependent on contractual rent increases than actual property-level improvement, making it vulnerable if operators face prolonged financial stress that impairs their ability to absorb even modest rent hikes, especially in an inflationary environment.

Omega Healthcare Investors faces mounting competitive pressures in its core skilled nursing and senior housing investment markets, which may constrain its ability to deploy capital at accretive yields despite a robust pipeline. Vikas Gupta acknowledged that the transaction market for U.S. senior housing and RIDEA structures is seeing “a lot of capital flowing into this space,” making it increasingly difficult to achieve the mid-teens IRRs the company targets. Similarly, in the SNF space, William John Kilichowski of Wells Fargo noted the market remains “heavily competitive,” with limited trading that fits OHI’s investment criteria, and Vikas Gupta confirmed they are “just not seeing a lot of trading at this time that we like and that fits our investment criteria.” This heightened competition risks forcing OHI to either lower its underwriting standards or sit on sidelines, potentially undermining its FAD per share growth trajectory. The company’s reliance on off-market deals and relationship-based sourcing, while a strength, may not be scalable enough to offset broad-based capital inflows that are compressing cap rates and reducing available spread. If OHI cannot consistently find value-add opportunities at its hurdle rates, its growth projections—particularly the mid-teens IRR RIDEA pipeline—could prove overly optimistic, leading to lower-than-expected reinvestment yields from asset sales like the CommuniCare disposition.
The Genesis bankruptcy exposure, while currently managed through a $25 million DIP loan funding, presents an unquantified risk that could materialize if the asset transfer to 101 West State Street fails or is delayed, potentially leaving OHI with impaired collateral and reduced recovery prospects. Although management expressed confidence that the term loan is “fully collateralized” and expects full payoff upon asset transfer, Vikas Gupta explicitly noted that “these assumptions, along with all elements of the bankruptcy process, are subject to further developments and events in the bankruptcy proceeding.” The closing date for the asset purchase agreement can be contractually extended to the end of Q3, and success is conditioned on regulatory change-of-ownership approval—an external factor outside OHI’s control. Any adverse development in the Genesis case, such as a rejection of lease obligations or a decline in the ascribed value of the estate, could result in a partial or total loss on the DIP and term loan exposure. While OHI frames this as a contained event, the lack of discussion around downside scenarios or stress testing suggests the market may be underestimating the binary nature of this risk, which could impact earnings and confidence if not resolved as anticipated.
Despite strong portfolio coverage metrics, Omega Healthcare Investors’ occupancy trends remain stagnant, calling into question the timing and durability of the expected recovery tied to demographic trends. Megan Krull acknowledged that “the past few quarters have kind of stagnated” and admitted there is “no read-through over a few quarters as to what occupancy is doing,” while expressing confidence that improvement will come “in the next year or two.” This vague outlook contrasts with the company’s reliance on gradual occupancy improvement as a driver of NOI growth and rent escalators, particularly in its triple-net portfolio. If occupancy fails to rebound as expected—due to persistent staffing shortages, shifting patient acuity, or slower-than-anticipated demographic demand—EBITDAR coverage could deteriorate, threatening the 1.58x ratio and increasing rent default risk. Furthermore, the company’s heavy reliance on annual rent escalators (which contributed $2 million to Q1 revenue growth) may mask underlying weakness in fundamental operating performance. The market may be ignoring the risk that OHI’s cash flow stability is more dependent on contractual rent increases than actual property-level improvement, making it vulnerable if operators face prolonged financial stress that impairs their ability to absorb even modest rent hikes, especially in an inflationary environment.

Counterparty Name Breakdown of Revenue (2021)

Peer Comparison

Companies in the REIT - Healthcare Facilities

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	WELL	Welltower Inc.	172.91 Bn	122.84	12.78	17.93 Bn
2	VTR	Ventas, Inc.	46.62 Bn	179.03	7.60	-
3	DOC	Healthpeak Properties, Inc.	15.34 Bn	69.22	-33.80	0.25 Bn
4	OHI	Omega Healthcare Investors Inc	15.14 Bn	23.22	12.25	0.43 Bn
5	AHR	American Healthcare REIT, Inc.	10.71 Bn	194.58	4.76	1.51 Bn
6	CTRE	CareTrust REIT, Inc.	9.45 Bn	28.24	199.40	0.50 Bn
7	HR	Healthcare Realty Trust Inc	7.33 Bn	-	5.04	4.10 Bn
8	SBRA	Sabra Health Care REIT, Inc.	5.09 Bn	36.93	17.13	0.04 Bn

Research Tools

Developers

About

Investment Thesis

Counterparty Name Breakdown of Revenue (2021)

Counterparty Name Breakdown of Revenue (2021)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Counterparty Name Breakdown of Revenue (2021)

Counterparty Name Breakdown of Revenue (2021)

Peer Comparison

Create an account

Sign In

Reset Password